Biology of Tongue Coating in Different Disease Stages of RA and Its Value in Disease Progression.

16S rRNA Disease activity Rheumatoid arthritis Tongue coating microbiota

Journal

Microbial pathogenesis
ISSN: 1096-1208
Titre abrégé: Microb Pathog
Pays: England
ID NLM: 8606191

Informations de publication

Date de publication:
12 Apr 2024
Historique:
received: 01 01 2024
revised: 04 04 2024
accepted: 10 04 2024
medline: 15 4 2024
pubmed: 15 4 2024
entrez: 14 4 2024
Statut: aheadofprint

Résumé

To assess and compare the composition of tongue coating microbiota among patients at different stages of rheumatoid arthritis (RA). A total of 47 patients diagnosed with RA, as per the American College of Rheumatology criteria, and 10 healthy individuals were enrolled in this study. The RA patients were stratified considering their Disease Activity Score 28 (DAS28), a composite measure based on the 28 tender and swollen joint count and erythrocyte sedimentation rate (ESR). The study population was further categorized into active phase group (LMH group) and inactive phase group (RE group) according to their DAS28 values. DNA extraction was extracted from tongue coating samples. Subsequently, the V3-V4 16S rDNA region was selectively amplified and sequenced through high-throughput 16S rDNA analysis. The resulting data were then utilized to ascertain the microbial contents. Significant variations were observed in the tongue coating microbiota of patients with RA during active and inactive phases, in comparison to healthy individuals (p < 0.05). At the genus level, the presence of Prevotellan, Veillonella, Rothia, and Neisseria in RA patients was notably more evident than in the healthy control (HC) group. These disparities find support in existing research on gut and oral microbiota. During the active phase of RA, the relative abundance of Veillonella, Rothia, and Neisseria in the tongue coating microbiota of patients was significantly higher than in those with inactive RA. These findings underscore the need for further and in-depth research on the potential impact of these microorganisms on the progression of RA disease. The results substantiate the hypothesis that tongue coating microbes actively contribute to the progression of RA.

Identifiants

pubmed: 38616001
pii: S0882-4010(24)00111-6
doi: 10.1016/j.micpath.2024.106644
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106644

Informations de copyright

Copyright © 2024. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest ☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. ☐ The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:

Auteurs

Qian Liu (Q)

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.

Kangle Shi (K)

Institute of Automation, University of Chinese Academy of Sciences, Beijing, China.

Yunjing Bai (Y)

Department of Rheumatism and Immunology, Seventh Medical Center of PLA General Hospital, Beijing, China.

Fangyan Yang (F)

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.

Cong Lei (C)

School of Basic Medicine, Heilongjiang University of Chinese Medicine.

Xiaocong Wang (X)

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.

Ying Hu (Y)

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.

Shiyao Wang (S)

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.

Ruikun Wang (R)

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.

Yuefan Yu (Y)

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.

Xiaoyu Liu (X)

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.

Xinping Yu (X)

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.

Lingling Zhang (L)

Department of Rheumatology and Clinical Immunology, Beijing Shijitan Hospital, Capital Medical University.

Ling Tang (L)

Nursing Department, DongFang Hospital of Beijing University of Chinese Medicine.

Suqian Li (S)

Department of Rheumatism and Immunology, DongFang Hospital of Beijing University of Chinese Medicine.

Qinggang Meng (Q)

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China. Electronic address: mengqg@bucm.edu.cn.

Classifications MeSH